This paper is in the following e-collection/theme issue:

Consumer & Patient Education and Shared-Decision Making (695) Cancer Survivorship (262) Design and Evaluation of Patient Education Materials (76) Patient Education for Cancer (154) Prostate Cancer (29) Demographics of Users, Social & Digital Divide (761) Use and User Demographics of mHealth (344) Vulnerable Populations in Health Research (104)

Published on in Vol 24, No 3 (2022): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/27890, first published .
Demographic and Psychosocial Characteristics Associated With Use of a Prostate Cancer Survivorship Website: Implications From a Multisite Randomized Controlled Trial

Demographic and Psychosocial Characteristics Associated With Use of a Prostate Cancer Survivorship Website: Implications From a Multisite Randomized Controlled Trial

Demographic and Psychosocial Characteristics Associated With Use of a Prostate Cancer Survivorship Website: Implications From a Multisite Randomized Controlled Trial

Authors of this article:

Allison Marziliano1 Author Orcid Image ;   Michael A Diefenbach1 Author Orcid Image ;   Shawna V Hudson2 Author Orcid Image ;   Erin K Tagai3 Author Orcid Image ;   Elizabeth A Handorf3 Author Orcid Image ;   Alicja Bator3 Author Orcid Image ;   Suzanne M Miller3 Author Orcid Image
Article Authors Cited by (4) Tweetations (5) Metrics

Allison Marziliano   1 , PhD ;   Michael A Diefenbach   1 , PhD ;   Shawna V Hudson   2 , PhD ;   Erin K Tagai   3 , PhD, MPH ;   Elizabeth A Handorf   3 , PhD ;   Alicja Bator   3 , MPH ;   Suzanne M Miller   3 , PhD

1 Center for Health Innovations and Outcomes Research, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, United States

2 Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ, United States

3 Cancer Prevention and Control, Fox Chase Cancer Center/Temple University Health System, Philadelphia, PA, United States

Corresponding Author:

  • Suzanne M Miller, PhD
  • Cancer Prevention and Control
  • Fox Chase Cancer Center/Temple University Health System
  • 333 Cottman Avenue
  • Philadelphia, PA, 19111
  • United States
  • Phone: 1 1-215-728-4069
  • Email: Suzanne.Miller@fccc.edu